OUR PEOPLE
Academic Credentials
- Ph.D., Medicine, University of Leicester, 2002
Professional Affiliations
- UK In Vitro Toxicology Society (Honorary member)
- Oct 2014 - present Senior Lecturer, University of Liverpool (Honorary position)
Dr. Mistry has a breadth of experience in experimental mammalian toxicology and pathology including crop protection research and development. Dr. Mistry has managed a portfolio of herbicide research projects through the bespoke design and interpretation of early investigative studies, aiding candidate selection and identifying unacceptable hazards early. Dr. Mistry led a comprehensive project from research into development incorporating toxicokinetics to guide dose-setting for chronic mammalian toxicity studies. The US EPA accepted this evidence-based scientific rationale to set appropriate dose levels studies based on dose limiting kinetics rather than dose-limiting toxicity. Dr. Mistry is an supporter for in vitro methods in toxicology and emerging technologies. Dr. Mistry has championed many initiatives supported by the National Centre of the Replacement, refinement and Reduction of Animal use and has chaired the UK In Vitro Toxicology Society. In addition, Dr. Mistry has written grant applications, successfully supervised four Ph.D students and contributed to numerous publications in the field; including a white paper on the utility of stem cells in Toxicology for a working group supported by the European Partnership for Alternative Approaches to Animal Testing.
Dr Mistry has helped develop and has supported numerous external collaborations exploring multidisciplinary approaches to help solve complex scientific challenges, such as mathematics in experimental in vitro models, through to innovative digital approaches for broader agricultural technology development. Dr Mistry has spent several years promoting external communication and collaboration, as well as developing approaches to survey competitor and technology intelligence. Prior to 11 years at a major crop protection company, Dr. Mistry worked in smaller start-up companies supporting the development of drug delivery systems, as well as a contract facility providing immunology, inflammation and infection expertise. Dr. Mistry also spent 9 years at University of Leicester studying and researching DNA damage and repair mechanisms, cell signaling and anti-cancer drugs, as well as managing a clinical trial.